Metraipolis › archive › dc_ec351e2380e8

SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence — Europe PMC PMID:41140367

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41140367
DOI
10.1155/jdr/5888495
License (as archived)
solo-consultazione
Archived
2026-11-09T06:28:52.897Z
SHA-256 of the archived text
859840377f87c4861a04be3182b9b0c13bc8bc53553b982eb1528fa10ef8e593
Stable URL of this page
https://metraipolis.com/documento/dc_ec351e2380e8

How to cite

SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence — Europe PMC PMID:41140367 — Europe PMC (en), https://europepmc.org/article/MED/41140367 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec351e2380e8 (Metraipolis archive dc_ec351e2380e8, sha256 859840377f87c4861a04be3182b9b0c13bc8bc53553b982eb1528fa10ef8e593)
BibTeX
@misc{dcec351e2380e8,
  title = {SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence — Europe PMC PMID:41140367},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41140367},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec351e2380e8; sha256 859840377f87c4861a04be3182b9b0c13bc8bc53553b982eb1528fa10ef8e593},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41140367. Agents can read the archived copy with the MCP tool read_document.